Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Notice convening the Annual General Meeting of Nobia AB (publ)

The shareholders of Nobia AB (publ), reg. no. 556528-2752 (“Nobia” or the “Company”), are hereby given notice of the Annual General Meeting to be held on Thursday, April 27, 2023 at 13:00 CEST at S:ta Clara, Klarabergsviadukten 90, Stockholm.Right to participate in the Annual General Meeting: Shareholders who wish to participate in the Annual General Meeting must: firstly be included in the shareholders register maintained by Euroclear Sweden AB (“Euroclear”) as of Wednesday, 19 April, 2023; and,secondly notify Nobia of their participation at the Annual General Meeting

Publication of Biohit Oyj Renumeration Report 2022

Biohit Oyj Renumeration Report March 22, 2023 at 9:30 am local time (EET) Biohit Oyj’s Remuneration Report for the Governing Bodies is published today in PDF format. The Remuneration Report for the Governing Bodies is attached to this stock exchange release and also available at https://www.biohithealthcare.com/en/investors/. Additional information: CEO Jussi Hahtela, Biohit Oyjtel. +358 9 773 861investor.relations@biohit.fiwww.biohithealthcare.com  Biohit in brief Biohit Oyj is a globally operating Finnish biotechnology company.

Implantica to repurchase own shares

Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, announces that the Board of Directors has decided to utilize the authorization given by the Annual General Meeting (AGM) on May 10, 2022, to repurchase own Shares (Swedish Depository Receipts representing class A shares in the company).The repurchase will start at the earliest on March 22, 2023, and may be conducted on one or more occasions until the next Annual General Meeting on May 25, 2023. The number of Shares to be acquired shall not exceed 200,000. The repurchased Shares will

Atlas Copco publishes its Annual Report for 2022

Nacka, Sweden, March 22, 2023: Atlas Copco has today published its Annual Report for 2022. It was another year with record orders, revenues, and operating profit.“We continue to focus on delivering value to our customers and continuously investing in people and innovation,” said Mats Rahmström, President and CEO of Atlas Copco Group. “During 2022, we continued our investments in R&D and entered new growth platforms. The combination of organic growth and successful acquisitions has shaped us into the Group we are today, and we continue to look for new technologies and segments that

Svenska Aerogel’s sustainability work is ISO 26000 verified – becomes the first Swedish listed company to be verified

Svenska Aerogel continues to develop its sustainability work. Now the company has become the first Swedish listed company to be verified according to ISO 26000, an international standard focusing on corporate social responsibility (CSR). The verification has been carried out by an accredited third party, VERIFY Agency of Sweden, which has reviewed Svenska Aerogel’s sustainability work as well as the self-declaration of the work.Tor Einar Norbakk, CEO of Svenska Aerogel: “The work that led to the ISO verification of our sustainability processes complements our already certified and

Crunchfish AB appoint new CEO of Crunchfish Gesture Interaction AB

Crunchfish have appointed Fredrik Clementson as the CEO of Crunchfish Gesture Interaction AB. Fredrik will replace Joakim Nydemark as head of the subsidiary. Simultaneously Patrik Lindeberg will take over the role as Chief Operating Officer Crunchfish AB from Joakim Nydemark. As earlier communicated , Joakim Nydemark, Chief Operating Officer Crunchfish AB and CEO of Crunchfish Gesture Interaction AB leaves his operational roles at Crunchfish and is proposed to join its board of directors. A recruitment process was

Publication of Biohit Oyj Annual Report 2022

Biohit Oyj Annual Financial Report March 22, 2023 at 09:30 am local time (EET) Biohit Oyj’s Annual Report 2022 is published today in PDF and XHTML format. The annual report contains financial statements for 2022, the Report of the Board of Directors and Corporate Governance Statements. Information in ESEF format has not been audited. Annual report is published in Finnish and English, and it can be read and downloaded from Biohit company website: Annual Reports - Biohit Healthcare  CEO Jussi Hahtela, Biohit Oyj tel.

NOTICE OF EXTRAORDINARY GENERAL MEETING IN PROSTATYPE GENOMICS AB (PUBL)

The shareholders in Prostatype Genomics AB (publ) reg. no. 556726-0285 (the “Company”) are hereby convened to the extraordinary general meeting on Friday 21 April 2023 at 10 AM at the Company´s office on Gustaf III:s Boulevard 34, 169 73 Solna.Right to participate in the general meeting Shareholders who wish to participate at the extraordinary general meeting shall: · on Thursday 13 April 2023 (the record date), be registered in the share register kept by Euroclear Sweden AB in their own names (not nominee-registered shares), and · notify the Company of his or her intention to

Dignitana enters Hong Kong market with leading distributor Science International Corporation

Scalp cooling innovator Dignitana AB  has signed Science International Corporation , a leading distributor for medical devices, to launch The DigniCap Scalp Cooling System in Hong Kong and Macao. Science International now becomes the exclusive provider of DigniCap in Hong Kong and Macau to minimize hair loss from chemotherapy. The company has already purchased two DigniCap Delta devices to introduce Dignitana’s clinically superior solution to the region.“Now is the time to bring this life-changing solution to our cancer patients,” said

BioStock: Patents and study in focus for Promore Pharma

When Promore Pharma looks back on 2022, it can look back on an eventful year with several important milestones achieved. 2023 does not promise to be any less hectic, in November the company announced that the results from the PHSU05 study with ensereptide for scarring on skin are expected to be available as early as April 2023. BioStock talked to CEO Jonas Ekblom about the past year and what awaits Promore Pharma.Read the full article about Promore Pharma at biostock.se: https://www.biostock.se/en/2023/03/patents-and-study-in-focus-for-promore-pharma/ This is a press release from

Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act

Nokian Tyres plc Stock Exchange Release March 22, 2023 at 9:10 a.m. Nokian Tyres has received an announcement from Bank of America Corporation on March 21, 2023, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement, the total holding in Nokian Tyres shares and voting rights owned by Bank of America Corporation exceeded the level of 5% of the share capital in Nokian Tyres plc, as a result of share transactions concluded on March 20, 2023. The total shareholding of Bank of America Corporation in Nokian Tyres has increased to 7,378,228

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 78 - 22 MARCH 2023 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 40/23 and 42/23.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Thomas France, Investor Communications Partner, tel.: 3315 0451

XNK presents at the 8[th] Innate Killer Summit in La Jolla, San Diego

XNK Therapeutics AB today announced its extensive participation at the 8[th] Annual Innate Killer Summit in La Jolla, San Diego, CA, March 28-30.The Annual Innate Killer Summit is the largest and leading technical, industry-focused, end-to-end innate immune cell therapy meeting to explore frontiers in immunobiology, genetic modification, clinical translation, scalable manufacturing, cryopreservation, and CMC. Over 200 experts from both pharmaceutical industry and academia participate to advance the clinical and phase development of NK, macrophage, γδT and NKT cell therapies for liquid and

Positive FDA Feedback to Progress Bexmarilimab

Faron Pharmaceuticals Oy (“Faron” or the “Company”) Inside Information: Faron Announces Positive US Food and Drug Administration (FDA) Feedback to Progress Bexmarilimab as a Monotherapy in Solid Tumors       Green light for continued clinical development after data package review       Alignment with company’s selection of 1 mg/kg IV once-every-3-weeks (Q3W) as dose for further evaluation       Supportive of biomarker-driven approach with CLEVER-1 staining of tumor biopsy Company announcement, March 22, 2023 at 03:00 AM (EDT) / 07:00 AM (GMT) / 09:00 AM (EET) Inside

THE LAST DAY FOR TRADING IN THE WARRANTS TO 4 AND TO 5 IS TODAY, 22 MARCH 2023

PRESS RELEASE THIS PRESS RELEASE MAY NOT BE RELEASED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, OR ANY OTHER JURISDICTION WHERE SUCH ACTION IN WHOLE OR IN PART IS SUBJECT TO LEGAL RESTRICTIONS. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO ACQUIRE SECURITIES IN CHROMOGENICS AB (PUBL). SEE ALSO THE “IMPORTANT INFORMATION” SECTION BELOW.Today, 22 March 2023, is the last day for trading in warrants of series TO 4 and TO 5 ("Warrants") issued in connection with

Fazer Group’s Annual Review 2022 published

Fazer’s Annual and Financial Reviews 2022 have been published today. The reports provide a deep insight into Fazer’s business and sustainability performance in 2022.Fazer performed well in 2022 in an environment reflected by soaring inflation, global supply chain challenges, and uncertainty regarding the war in Ukraine. The Annual Review describes in detail our strategic development, business performance, and market environment.   Sustainability plays a prominent role in all our operations and is an integral element of Fazer Group’s strategy. The Annual Review provides insight into our

Assemblin acquires staffing business, strengthening its electrical operations

Assemblin Norway has acquired the assets of staffing company MV Elektro AS (“MV Elektro”) in Oslo, with 20 employees. The acquisition strengthens Assemblin’s capacity in the area of electrical installations.MV Elektro was established in 2011 and has provided staffing solutions for several contractors and a wide range of construction projects, mainly in the Oslo region. Earlier this year, Assemblin also completed its acquisition of staffing company Ariemi AS, which primarily offers outsourced labour in the areas of heating and sanitation. With the acquisition of MV Elektro, Assemblin also

Mycronic receives order for an SLX mask writer

Mycronic AB (publ) has received an order for an SLX mask writer from a new SLX customer, for delivery to the United States. The order value is in the range of USD 3-5 million. Delivery of the system is planned for the second quarter of 2023.The SLX laser mask writer meets rising demand for photomasks for the semiconductor industry and a future need for replacement and modernization. Photomasks manufactured by laser mask writers are of high importance and account for a majority of all photomasks produced for semiconductor manufacturing. SLX is a modern and energy efficient mask writer based

Kuusakoski invests in first carbon free steel recycling plant

Press release 22nd March 2023 at 09:00 EETEspoo, Finland Recycling pioneer Kuusakoski plans to invest 25M€ in building a steel recycling plant that will operate 100% carbon free. The plant will be located in Veitsiluoto, a well-known industrial site located in the Northern Gulf of Bothnia, Finland.Kuusakoski, a forerunner of the green transition, is going to build a market first steel recycling plant that will operate 100% carbon free and utilise the latest technology. The investment responds to growing demand for recycled metals in Finland and Sweden, and it will increase the annual

The Nomination Committee’s proposal regarding the Board of Directors for the annual shareholders’ meeting in Polygiene AB (publ)

The Nomination Committee of Polygiene Group AB proposes re-election of Jonas Wollin, Håkan Lagerberg, Pamela Ravasio, Paul Morris as ordinary Board members, to elect Bengt Engström as new ordinary Board members, and to re-elect Jonas Wollin as Chairman of the Board.The Nomination Committee has consisted of Håkan Lagerberg, representing Håkan Lagerberg and Mastan AB, Paul Morris, representing Paul Morris with family, Peter Gyllenhammar, and Jonas Wollin, Chairman of the Board. The Chairman of the Nomination Committee has been Paul Morris. The Nomination Committee proposes that the annual

Q4 Report - 31 December 2022

Flexion closes its strongest year to date with another record quarter. Total revenue grows by 108%, gross profit up 147% and adjusted EBITDA hits GBP 1.6mOctober-December 2022 performance · Total revenue increased by 108% to GBP 21.7m (10.5)* · Gross profit increased by 147% to GBP 3.7m (1.5) · Adjusted EBITDA[‡] increased to GBP 1.6m (0.4) · Adjusted profit before tax[#] increased to GBP 1.1m (0.6) · EPS amounted to GBP 2.78 pence (1.28 pence) · Adjusted EPS amounted to GBP 1.88 pence (1.32 pence) · Operating cash flow amounted to GBP 1.2m (0.5) · Cash and cash

Ovzon's result for 2022 negatively affected by further provisions of MSEK 34 for bad debt

Following newly unveiled information regarding the financial situation of its Italian distributor, Ovzon has chosen to make further provisions for bad debt related to the distributor. The parties have agreed on a payment plan and Ovzon has secured receivables through a pledge on the distributor’s assets. The provision is nevertheless made as a precautionary measure. As a result, the company’s previously published result in the year-end report 2022 is negatively affected by an additional MSEK 34. The result for the fourth quarter of 2022 amounts therefore to MSEK -43 (previously MSEK -8) and

There are no items matching the current filter
There are no more items matching the current filter
Back to top